Prednisolone has been approved in the Other Countries

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.


Prednisolone studies

Select the study ID number to view the trial summary

Study IDPhaseTitle
RA4104917 II A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety and tolerability, pharmacokinetics (PK) and effect on synovial thickness and vascularity of 28 days repeat dosing of investigational product or 7.5 mg prednisolone in rheumatoid arthritis (RA) subjects.
ONG105414 I A study to investigate the effects of orally administered single dose prednisolone on carbohydrate metabolism using oral glucose tolerance testing.